Cheri M. Taylor Ph.D.

Partner

Cheri Taylor focuses on litigation in biotechnology, pharmaceuticals, and chemical patents, including Abbreviated New Drug Application (ANDA) litigation. She also counsels clients on patent portfolios and acquisitions in the area of biotechnology.

Dr. Taylor is a regular instructor on the topic of claim construction and proving infringement at the Practising Law Institute.

Highlights

• Represented innovator pharmaceutical companies in defending their patents against infringement by generic manufacturers resulting in favorable settlements.
• Represented plaintiff L'Oréal in defending a patent relating to cosmetics packaging against Revlon resulting in favorable settlement on the eve of trial.
• Represented Organon Teknika Corporation in asserting its nucleic acid sequence-based amplification (NASBA) technology against Hoffmann-La Roche's polymerase chain reaction (PCR) technology for amplification of DNA in U.S. district court and U.S. International Trade Commission (ITC) actions.
• Conducted due diligence for clients on the potential acquisition of patent portfolios in the area of biotechnology.
• While a staff attorney at the ITC, was involved in seven Section 337 investigations, including the Commission's first biotechnology case, Certain Recombinant Erythropoietin Inv. No. 337-TA-281; and served as lead counsel in the first temporary relief investigation conducted under Section 337, Certain Crystalline Cefadroxil Monohydrate Inv. No. 337-TA-293.
• Taught science courses at the secondary and college levels.

Professional Recognition

• AV^® rated by Martindale-Hubbell.
• Selected as a member of The International Who's Who of Life Sciences Lawyers, 2008.
• Recipient of the American Jurisprudence Book Award in Civil Procedure.

Professional Activities

• Federal Circuit Bar Association
• ITC Trial Lawyers Association
• American Bar Association (member, Intellectual Property Section; chair, Subcommittee 603-International Trade Commission, 1997-1998; chair, Committee 603-International Trade Commission, 1998-1999 and 1999-2000; chair, Committee 1004-Chemical Patent Practice, 2000-2001 and 2001-2002; chair, Committee 1003-Animal Patent Practice, 2002-2003; division X chair, 2003-2004 and 2004-2005; co-chair, Committee 108-Patent System Policy Planning, 2005-2006; council, Intellectual Property Law Section, 2006-2010; ABA Presidential Appointment to the Special Committee on Bioethics and the Law, 2006-2007 and 2007-2008)
• D.C. Women’s Bar Association
• American Intellectual Property Law Association (AIPLA)

Select Publications

• Coauthor. "Antitrust at the ITC? Alternative Uses of Section 337," The Antitrust News, AIPLA Commission on Antitrust Law, April 1995.